By Mike
Chemotherapy is often the only choice cancer sufferers have to regain a next-to-normal health condition. In oncology, adjuvant plays an important role particularly in combination with other cancer treatments. Adjuvant is an additional treatment administered to the patient following a surgical intervention as a means to prevent the possible development of the cancer cells that may have remained after the removal. The patient may relapse even if surgery has been performed because unfortunately, medicine is not sufficiently developed to be able to foresee whether cancer cells will reoccur or not. Radiotherapy or regular chemical-based treatments are included in the adjuvant category and they are recommended by the doctors based on some statistical evidence which is employed in order to figure out whether there is low or high risk in relapse for the patient. Statistics show that about a third of the patients who have undergone adjuvant treatment have resumed good health only through surgical intervention. For the less fortunate ones, the long term aim of the adjuvant is to lengthen the life of the cancer patients. The types

Processed Meat May Harm the Heart (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- Conventional wisdom has dictated that fat from red meat is a risk factor for heart disease, but a new analysis from Harvard researchers finds it's eating processed meat -- not unprocessed red meat -- that increases the risk for heart disease and even diabetes.
Sunlight May Help Protect Men From Kidney Cancer (HealthDay)
HealthDay - MONDAY, March 8 (HealthDay News) -- Men with jobs that expose them to high levels of sunlight are less likely to develop kidney cancer than those with little or no sunlight exposure at work, says a new study.
Breast Cancer Patients Often Confused by Genomic Testing (HealthDay)
HealthDay - MONDAY, March 8 (HealthDay News) -- Doctors need to do a better job of explaining genomic test results to breast cancer patients, say U.S. researchers.
Proteins May Predict Spread of Colon Cancer (HealthDay)
HealthDay - MONDAY, March 8 (HealthDay News) -- Two proteins that might serve as biomarkers for predicting the spread of colon cancer have been identified by Chinese scientists.
Specialty may bias doctors' prostate cancer advice (Reuters)
Reuters - New research suggests that the type of specialist a prostate cancer patient sees -- rather than the patient's own preference -- may determine the treatment he receives.
Certain Bone Drugs May Lower Breast Cancer Risk (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- Some types of bone-building drugs used to prevent and treat osteoporosis might reduce the risk of breast cancer, according to new research.
New Prostate Cancer Guidelines Aim to Empower the Patient (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- New American Cancer Society guidelines on prostate cancer screening mean that many men will be faced with a cascade of decisions, with a growing responsibility for those decisions falling on their shoulders.
Freezing Technique May Stop Breast Cancer (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- Freezing breast tumors helped stop the spread of the cancer in mice, a new study has found.
Smoking tied to lung cancer in women with HIV (Reuters)
Reuters - Women infected with HIV or at risk of becoming infected with HIV, the virus that causes AIDS, appear more likely to develop lung cancer than women in the general population, possibly because they are much more likely to smoke cigarettes, study findings hint.
New Drugs, Approaches Offer Hope Against Prostate Cancer (HealthDay)
HealthDay - WEDNESDAY, March 3 (HealthDay News) -- Scientists are making headway in finding ways to treat and detect stubborn forms of prostate cancer.

of cancer in which adjuvant is used are quite various and here we may include colon cancer, lung, pancreatic, breast and prostate cancer as well as some forms of gynecological cancers. In terms of parallel treatments, adjuvant is complemented by neo-adjuvant chemotherapy. The latter is given to patients before the primary treatment and it may take the form of chemical drug-based treatment. For example, neo-adjuvant could be used in the case of a patient suffering from breast cancer who will have to undergo surgery for breast removal. The aim of such a type of therapy is to reduce the size of the tumor so that the surgery may be performed more efficiently and with less risk. All in all, adjuvant has been identified as more rewarding in results when it is prescribed after the tumor removal rather than before it because the remaining cancer cells are fewer in number and, as a result, the drug is more powerful on them. As for the drug efficiency, the level is a lot higher when the treatment is administered intravenously; another way of increasing drug effects is to insert it directly into the part of the body that is affected by cancer.
This article is written by Mike